Ashland Global Holdings Inc. today announced it has completed the previously announced sale of its Composites business (excluding the Maleic business) and butanediol manufacturing facility in Marl, Germany to INEOS Enterprises in a transaction valued at $1.015 billion.
Net proceeds from the sale are approximately $930 million. Over $400 million of debt has been retired and an additional $500 million is expected to be retired by the end of the week.
“The sale of our Composites and Marl businesses allows Ashland to focus on our vision of becoming the premier specialty chemicals company,” said Bill Wulfsohn, Ashland chairman and chief executive officer. “We believe this transaction, when combined with our cost reduction program, will help better position Ashland to deliver sustained earnings growth and significant value for shareholders.”
Citi acted as financial advisor to Ashland, and Squire Patton Boggs LLP acted as legal advisor.
US chemicals firm Dow has developed and commercialized a formulated post-consumer recycled (PCR) plastic resin in Asia-Pacific. Such initiatives threaten virgin plastic demand, but it will take time for recycling […]
The oil price crash under the weight of the Covid-19 pandemic has brought mixed fortunes for the petrochemical industry. In 2019, the Brent crude benchmark hovered around $60 a barrel, […]
Borealis has announced the appointment of Erik van Praet as vice president innovation & technology effective 1 April 2020. Van Praet succeeds Maurits van Tol, who last year moved to […]